Susan Orr
Director/Board Member bei OPTHEA LIMITED
Vermögen: - $ am 30.04.2024
Profil
Susan Orr is a professional with current positions as Non-Executive Director at Opthea Ltd., Director at Retina Global, and Chief Medical Officer at Claris Biotherapeutics, Inc. She previously worked as Chief Executive Officer at Notal Vision Ltd.
from 2016 to 2019.
Orr received her undergraduate and doctorate degrees from The University of Waterloo.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
OPTHEA LIMITED
-.--% | 28.09.2023 | 0 ( -.--% ) | - $ | 30.04.2024 |
Aktive Positionen von Susan Orr
Unternehmen | Position | Beginn |
---|---|---|
OPTHEA LIMITED | Director/Board Member | 21.04.2022 |
Claris Biotherapeutics, Inc.
Claris Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Claris Biotherapeutics, Inc. engages in the manufacturing of drugs. The company was founded in 2018 and is headquartered in Jersey City, NJ. | Chief Operating Officer | - |
Retina Global | Director/Board Member | - |
Ehemalige bekannte Positionen von Susan Orr
Unternehmen | Position | Ende |
---|---|---|
Notal Vision Ltd.
Notal Vision Ltd. Medical/Nursing ServicesHealth Services Notal Vision Ltd. develops and manufactures computerized ophthalmic diagnostic devices. It develops age-related macular degeneration (AMD) monitor for patients at risk of vision loss from the devastating effects of wet AMD. The firm provides Preferential Hyperacuity Perimetry, a technology with clinical data for monitoring patients with AMD to eye care professionals. Its products are used for the detection and characterization of central and paracentral metamorphopsia in patients as an aid in monitoring progression of disease factors causing metamorphopsia, such as choroidal neovascularization. The company was founded in 2000 by Barak Azmon and Yair Alster and is headquartered in Tel Aviv, Israel. | Chief Executive Officer | 23.10.2019 |
Ausbildung von Susan Orr
The University of Waterloo | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
OPTHEA LIMITED | Health Technology |
Private Unternehmen | 3 |
---|---|
Notal Vision Ltd.
Notal Vision Ltd. Medical/Nursing ServicesHealth Services Notal Vision Ltd. develops and manufactures computerized ophthalmic diagnostic devices. It develops age-related macular degeneration (AMD) monitor for patients at risk of vision loss from the devastating effects of wet AMD. The firm provides Preferential Hyperacuity Perimetry, a technology with clinical data for monitoring patients with AMD to eye care professionals. Its products are used for the detection and characterization of central and paracentral metamorphopsia in patients as an aid in monitoring progression of disease factors causing metamorphopsia, such as choroidal neovascularization. The company was founded in 2000 by Barak Azmon and Yair Alster and is headquartered in Tel Aviv, Israel. | Health Services |
Claris Biotherapeutics, Inc.
Claris Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Claris Biotherapeutics, Inc. engages in the manufacturing of drugs. The company was founded in 2018 and is headquartered in Jersey City, NJ. | Health Technology |
Retina Global |